Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Tandem Diabetes Care (TNDM) over the last 3 years, with Q3 2025 value amounting to $2.1 million.

  • Tandem Diabetes Care's Interest Expenses rose 1072.39% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 453.93%. This contributed to the annual value of $7.4 million for FY2024, which is 2496.46% down from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Interest Expenses is $2.1 million, which was up 1072.39% from $1.9 million recorded in Q2 2025.
  • Tandem Diabetes Care's Interest Expenses' 5-year high stood at $4.8 million during Q3 2023, with a 5-year trough of $1.6 million in Q2 2023.
  • In the last 3 years, Tandem Diabetes Care's Interest Expenses had a median value of $1.9 million in 2024 and averaged $2.1 million.
  • Over the last 5 years, Tandem Diabetes Care's Interest Expenses had its largest YoY gain of 1171.34% in 2024, and its largest YoY loss of 6146.69% in 2024.
  • Quarter analysis of 3 years shows Tandem Diabetes Care's Interest Expenses stood at $1.8 million in 2023, then rose by 3.16% to $1.9 million in 2024, then grew by 11.02% to $2.1 million in 2025.
  • Its Interest Expenses stands at $2.1 million for Q3 2025, versus $1.9 million for Q2 2025 and $1.9 million for Q1 2025.